Isis appoints chief business officer
This article was originally published in Scrip
Executive Summary
Isis Pharmaceuticals has named Sarah Boyce chief business officer. In this newly created position, Ms Boyce will provide strategic leadership from a commercial background and lead Isis' corporate development activities. Prior to joining California-based Isis, Ms Boyce was vice-president, head of international business strategy and operations at Forest Laboratories.